Tuesday, November 19, 2019 9:47:39 AM
BioNeutra International Ltd. (TICKER SYMBOL: BIMO) has entered into an Agreement with PHARMAZON which uses the two basic fundamentals of Amazon, provide the best price and provide convenience by providing same day or next day delivery to the consumers home or office. PHARMAZON is applying these basic fundamentals to the pharmaceutical business on a GLOBAL scale. This is necessary for economies of scale. PHARMAZON is a unique disruptor company in that it recognizes that the rules and regulations concerning the pharmaceutical business are set on a parochial basis, (State, Province, Country) but diseases (i.e. diabetes) have no borders and is a world wide problem. Medicines should be available at the same low price for every diabetic wherever they are in the world. Right now in one country the very same medicine manufactured by a generic manufacturer in Turkey is $10 in the Caribbean, $40 dollars in Canada and $110 dollars in the USA. PHARMAZON will provide the medication at $12-$15 dollars (delivered) world wide. The Agreement between PHARMAZON and BIMO is a non arms length transaction through common management.
https://pharmazon.ltd/
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM